Sheryl Skolnick Upgraded (AMED) to Strong Buy on, Nov 7th, 2016
Sheryl, nor any peers, have made any analyst calls on AMED in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
on: Thu, Nov 03rd 2016
by: WOPRAI
Michael Rose Upgraded (TCBI) to Strong Buy on, Nov 3rd, 2016
on: Wed, Nov 02nd 2016
by: WOPRAI
Christian Schwab Upgraded (CALX) to Strong Buy on, Nov 2nd, 2016
on: Thu, Apr 07th 2016
by: WOPRAI
on: Thu, Mar 10th 2016
by: WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Increased Target to $45 on, Mar 10th, 2016
on: Mon, Feb 08th 2016
by: WOPRAI
on: Tue, Jan 19th 2016
by: WOPRAI
Sheryl Skolnick Upgraded (AMED) to Strong Buy on, Jan 19th, 2016
on: Wed, Jan 13th 2016
by: WOPRAI
Whit Mayo Maintained (AMED) at Hold with Decreased Target to $39 on, Jan 13th, 2016
on: Mon, Jan 11th 2016
by: WOPRAI
on: Wed, Nov 11th 2015
by: WOPRAI
Sheryl Skolnick Downgraded (AMED) to Hold and Held Target at $45 on, Nov 11th, 2015
on: Wed, Jul 01st 2015
by: WOPRAI
Sheryl Skolnick Initiated (AMED) at Strong Buy and Held Target at $45 on, Jul 1st, 2015
on: Tue, Jun 09th 2015
by: WOPRAI
Justin Bowers Upgraded (AMED) to Strong Buy and Increased Target to $41 on, Jun 9th, 2015
on: Wed, Nov 12th 2014
by: WOPRAI
Christopher Growe Upgraded (THS) to Strong Buy and Held Target at $90 on, Nov 12th, 2014